SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-029044
Filing Date
2017-05-01
Accepted
2017-05-01 20:20:56
Documents
1
Period of Report
2017-04-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3335
  Complete submission text file 0001209191-17-029044.txt   4797
Mailing Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025 650-272-6269
Adverum Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE SANSOME STREET SUITE 3630 SAN FRANCISCO CA 94104
Business Address
Woiwode Thomas (Reporting) CIK: 0001619294 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36579 | Film No.: 17802598